FDA NDC Directory · JSON-LD · Markdown

JUVMO

NDC 0074-6315 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameTavapadon
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA220415
Dosage form / routeTABLET · ORAL
Active ingredientsTAVAPADON (15 mg/1)
Marketing started20260925
Package count1

External sources

Source: openFDA. Public-domain (CC0).